{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04724252",
            "orgStudyIdInfo": {
                "id": "1571754"
            },
            "organization": {
                "fullName": "University of California, Davis",
                "class": "OTHER"
            },
            "briefTitle": "Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children",
            "officialTitle": "Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children",
            "therapeuticArea": [
                "Other"
            ],
            "study": "gabapentin-to-reduce-opioid-use-postoperatively-group-in-children"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-08-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-01-21",
            "studyFirstSubmitQcDate": "2021-01-25",
            "studyFirstPostDateStruct": {
                "date": "2021-01-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-06-12",
            "lastUpdatePostDateStruct": {
                "date": "2023-06-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of California, Davis",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery.\n\nWe hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not given gabapentin",
            "detailedDescription": "This study is a double-blind, placebo controlled, randomized study to explore the effects of gabapentin peri and post operatively. Physician and families will be blinded to the treatment.\n\n60 subjects will be randomized in a 1:1 ratio to either:\n\n* Gabapentin treatment group\n* Placebo - control group\n\nWe aim to understand the impact that gabapentin use peri and post operatively has on:\n\n1. opioid use based of IV morphine\n2. pain scores\n3. opioid related complications such as withdrawal\n4. effects on the level of sedation\n5. Possible adverse effects associated with use of gabapentin\n6. Time to extubating\n\nThe duration of an individual subject's participation in the study will be 7 days or until the patient is discharged from UC Davis Hospital, whichever occurs first."
        },
        "conditionsModule": {
            "conditions": [
                "Pain, Postoperative"
            ],
            "keywords": [
                "thoracic surgery",
                "cardiac surgery via a sternotomy or thoracotomy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Children meeting criteria will be randomized in a 1:1 ratio using 4 blocked randomization to either gabapentin or placebo (in addition to standard of care pain control treatment):",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "maskingDescription": "This study is a double-blind, placebo controlled, randomized study. Physician and families will be blinded to the randomization.",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Gabapentin Treatment",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Given at a dose of 10mg/kg (max 600mg) perioperatively (immediately prior to surgery) followed by 3mg/kg/dose TID with first dose to be given starting at 8 hours post perioperative dose.",
                    "interventionNames": [
                        "Drug: Gabapentin"
                    ]
                },
                {
                    "label": "Control Group",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Given placebo which coincides with the active treatment group",
                    "interventionNames": [
                        "Other: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Gabapentin",
                    "description": "Determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after surgery.",
                    "armGroupLabels": [
                        "Gabapentin Treatment"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Placebo",
                    "description": "Control Arm",
                    "armGroupLabels": [
                        "Control Group"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Amount of pain medication needed.",
                    "description": "Amount of pain medication needed after surgery",
                    "timeFrame": "7 days post-operative or until discharge, whichever came first"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age newborn to \\< 18 years.\n2. Gestational age to be minimum 38 weeks.\n3. Undergo cardiac surgery via a sternotomy or thoracotomy.\n4. Any Thoracic Surgery\n5. Planned noncardiac surgery via a thoracotomy or Video Assisted Thoracotomy (VATS).\n6. Surgery will result in an inpatient stay of at least 48 hours.\n\nExclusion Criteria:\n\n1. Use of opioids within 30 days prior to study entry.\n2. Renal Failure as defined by RIFLE Criteria.\n3. History of seizures requiring active treatment.\n4. History of chronic pain treated medically.\n5. Diagnosis of Autism.\n6. Unable to tolerate enteral medications.\n7. Hematology/Oncology patients.\n8. Parents/legal guardians unable to consent.\n9. Participation in another clinical study presently or within the last 30 days\n10. Pregnancy\n11. Prisoners",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "17 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "locations": [
                {
                    "facility": "UC Davis Medical Center",
                    "status": "RECRUITING",
                    "city": "Sacramento",
                    "state": "California",
                    "zip": "95817",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Katrina Falwell, BSN",
                            "role": "CONTACT",
                            "phone": "916-453-2134",
                            "email": "kafalwell@ucdavis.edu"
                        },
                        {
                            "name": "Michaela Canova, BS",
                            "role": "CONTACT",
                            "phone": "916-453-2124",
                            "email": "mecanova@ucdavis.edu"
                        },
                        {
                            "name": "Gary Raff, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.58157,
                        "lon": -121.4944
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Learn more or sign up for the study here!",
                    "url": "https://studypages.com/s/a-study-of-gabapentin-to-reduce-opioid-use-after-surgery-in-children-the-group-study-210128/"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010149",
                    "term": "Pain, Postoperative"
                }
            ],
            "ancestors": [
                {
                    "id": "D000011183",
                    "term": "Postoperative Complications"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000010146",
                    "term": "Pain"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13069",
                    "name": "Pain, Postoperative",
                    "asFound": "Pain, Postoperative",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M14065",
                    "name": "Postoperative Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077206",
                    "term": "Gabapentin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000927",
                    "term": "Anticonvulsants"
                },
                {
                    "id": "D000014151",
                    "term": "Anti-Anxiety Agents"
                },
                {
                    "id": "D000014149",
                    "term": "Tranquilizing Agents"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018691",
                    "term": "Excitatory Amino Acid Antagonists"
                },
                {
                    "id": "D000018683",
                    "term": "Excitatory Amino Acid Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018692",
                    "term": "Antimanic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                },
                {
                    "id": "M12245",
                    "name": "Narcotics",
                    "relevance": "LOW"
                },
                {
                    "id": "M1694",
                    "name": "Gabapentin",
                    "asFound": "Guidance",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4246",
                    "name": "Anticonvulsants",
                    "relevance": "LOW"
                },
                {
                    "id": "M16905",
                    "name": "Anti-Anxiety Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M20771",
                    "name": "Excitatory Amino Acid Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AntiConv",
                    "name": "Anticonvulsants"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                }
            ]
        }
    },
    "hasResults": false
}